The FDA is currently shifting its organizational and technology infrastructures to facilitate electronic interactions with the companies it regulates.
Results from this Axendia research, commissioned by MasterControl, are now available in a Whitepaper entitled: The Future of the FDA: Operating in an “Electronic World”
This Whitepaper details FDA’s movement to electronic interactions and is based on interviews with key FDA officials who shared major transformational activities that:
- Promise to usher in a new era of electronic interactions between the FDA and its constituents
- Move towards working in an environment where all regulated product information comes in electronically, whether it be product quality, manufacturing, pre-market, or post market data
To download The Future of the FDA: Operating in an “Electronic World” Whitepaper and read the accompanying FDA’s e-Transformation Initiatives article series visit: http://lsp.axendia.com/fda-e-transformation-study/
Findings and detailed analysis from this study will be presented at the INTERPHEX PharmaMedDevice Symposium scheduled for March 19, 2009 at 9:00AM (Session PMD14) at the Jacob K. Javits Convention Center in NY.